Zdrowie i gospodarka · 29/08/2014
FDA Clears JADELLE Implant for Approval
The FDA has determined that the 75mg JADELLE levonorgestrel implant was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.